tibolone has been researched along with Weight Gain in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blake, GM; Fogelman, I; Patel, R; Rajamanohara, R; Robinson, J; Rymer, J | 1 |
| Benhamou, CL; Garnero, P; Jamin, C; Pelissier, C; Roux, C | 1 |
| Dedeoğlu, EN; Erenus, M; Yörük, P | 1 |
| Chao, KC; Lee, WL; Liu, CM; Wang, PH; Yen, MS | 1 |
| Butler, D; Ginsburg, J; Okolo, S; Prelevic, G | 1 |
| Hosoi, T; Ikegami, A; Kasugai, Y; Matsuo, K; Ohashi, M; Orimo, H; Ouchi, Y; Sukamoto, T | 1 |
| Baracat, EC; Barbosa, IC; Giordano, MG; Haidar, MA; Marinho, RM; Menegocci, JC; Morais, KM; Tomaz, G; Wehba, S | 1 |
5 trial(s) available for tibolone and Weight Gain
| Article | Year |
|---|---|
The effect of weight and weight change on the long-term precision of spine and hip DXA measurements.
Topics: Absorptiometry, Photon; Aged; Body Mass Index; Body Weight; Bone Density; Estrogen Receptor Modulators; Female; Femur Neck; Follow-Up Studies; Hip Joint; Humans; Lumbar Vertebrae; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal; Phantoms, Imaging; Retrospective Studies; Weight Gain | 2011 |
Effects of tibolone and combined 17beta-estradiol and norethisterone acetate on serum C-reactive protein in healthy post-menopausal women: a randomized trial.
Topics: Adult; C-Reactive Protein; Estradiol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Weight Gain | 2002 |
Effects of hormone therapy and tibolone on body composition and serum leptin levels in postmenopausal women.
Topics: Adiposity; Adult; Body Mass Index; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Leptin; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Postmenopause; Time Factors; Treatment Outcome; Waist-Hip Ratio; Weight Gain | 2009 |
Clinical experience with tibolone (Livial) over 8 years.
Topics: Aged; Climacteric; Estrogen Replacement Therapy; Female; Humans; Menstruation Disturbances; Middle Aged; Norpregnenes; Postmenopause; Time Factors; Treatment Outcome; Weight Gain | 1995 |
A randomized, open-label study of conjugated equine estrogens plus medroxyprogesterone acetate versus tibolone: effects on symptom control, bleeding pattern, lipid profile and tolerability.
Topics: Aged; Animals; Coitus; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Female Urogenital Diseases; Horses; Hot Flashes; Humans; Lipids; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Postmenopause; Uterine Hemorrhage; Weight Gain | 2002 |
2 other study(ies) available for tibolone and Weight Gain
| Article | Year |
|---|---|
The short-term effect of increased body weight in menopausal Chinese women taking tibolone.
Topics: Adiposity; Estrogen Receptor Modulators; Female; Humans; Norpregnenes; Patient Compliance; Postmenopause; Weight Gain | 2008 |
Effects of tibolone (Org OD14) treatment for 3 months on ovariectomy-induced osteopenia in 8-month-old rats on a low-calcium diet: preventive testing for 3 months.
Topics: Administration, Oral; Amino Acids; Anabolic Agents; Animals; Antineoplastic Agents, Hormonal; Biomarkers; Bone Density; Bone Diseases, Metabolic; Bone Resorption; Calcium; Cholesterol; Creatinine; Female; Femur; Humans; Hydroxyproline; Lumbar Vertebrae; Norpregnenes; Osteocalcin; Ovariectomy; Rats; Rats, Sprague-Dawley; Weight Gain | 1998 |